Latest news for health care topics. Include medical news , health insurance , therapy and vaccine news

Friday, December 2, 2016

Why It’s So Hard to Make an HIV Vaccine quoting : time

This content may collect you by Lucy William

We will quote to you most important and trendy news about all kind of Vaccine of the best health sites Like : "time" and the most famous medical experts : Alexandra Sifferlin


daily : 2016-12-02 & on time : 14:16


according to





Why It's So Hard to Make an HIV Vaccine


Why It's So Hard to Make an HIV Vaccine
image uploaded by "time" site
The first HIV vaccine trial in seven years is launching in South Africa.The trial is called HVTN 702, and the goal is to enroll 5,400 sexually active men and women between 18 and 35 throughout South Africa, where more than 1,000 people are infected with HIV each day.It's the most ambitious HIV vaccine trial launched so far.
about the details read more from here


New, Genetically-Modified HIV Vaccine Enters Next Phase of Trials


New, Genetically-Modified HIV Vaccine Enters Next Phase of Trials
image uploaded by "vice" site
Image: U.S. Army Corps of Engineer/FlickrA new possible HIV vaccine that uses a genetically-modified version of the virus is heading into Phase II trials.The results of an earlier trial showed it provoked an immune response against the virus, but now we need to see if that response is strong enough to protect someone from getting infected with HIV in the first place.The vaccine uses an inactivated—or "dead"—version of the HIV virus, the first vaccine of this type for HIV.
about the details read more from here


First New HIV Vaccine Efficacy Study in Seven Years Has Begun


First New HIV Vaccine Efficacy Study in Seven Years Has Begun
image uploaded by "nih" site
The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults.The study, called HVTN 702, involves a new version of the only HIV vaccine candidate ever shown to provide some protection against the virus.HVTN 702 aims to enroll 5,400 men and women, making it the largest and most advanced HIV vaccine clinical trial to take place in South Africa, where more than 1,000 people become infected with HIV every day.
about the details read more from here


New HIV Vaccine Study Starts in South Africa


New HIV Vaccine Study Starts in South Africa
image uploaded by "livescience" site
A new HIV vaccine is now being tested in South Africa in a study that aims to enroll several thousand people, officials announced today.The study is the first in seven years to test the effectiveness of a vaccine against HIV, said the National Institutes of Health (NIH), which is funding the study."If deployed alongside our current armory of proven HIV-prevention tools, a safe and effective vaccine could be the final nail in the coffin for HIV," Dr. Anthony Fauci, director of the NIH's National Institute of Allergy and Infectious Diseases, said in a statement.
about the details read more from here


To follow all the new news about Vaccine

No comments:

Post a Comment